Robak T - Search Results

1

Experimental drugs in clinical trials for acute myeloid leukemia: innovations, trends, and opportunities.

Gołos A, Góra-Tybor J, Robak T. Gołos A, et al. Among authors: robak t. Expert Opin Investig Drugs. 2023 Jan;32(1):53-67. doi: 10.1080/13543784.2023.2171860. Epub 2023 Jan 29. Expert Opin Investig Drugs. 2023. PMID: 36669827

2

Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment.

Robak T, Boński JZ, Kasznicki M, Góra-Tybor J, Hellmann A, Konopka L, Dmoszyńska A, Dwilewicz-Trojaczek J, Wołowiec D; Polish Leukemia Study Group. Robak T, et al. Eur J Haematol. 2002 Jul;69(1):27-36. doi: 10.1034/j.1600-0609.2002.02711.x. Eur J Haematol. 2002. PMID: 12270059

3

Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia.

Robak T, Błoński JZ, Kasznicki M, Góra-Tybor J, Dwilewicz-Trojaczek J, Stella-Hołowiecka B, Wołowiec D. Robak T, et al. Hematol J. 2002;3(5):244-50. doi: 10.1038/sj.thj.6200191. Hematol J. 2002. PMID: 12391542 Clinical Trial.

4

Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.

Gora-Tybor J, Blonski JZ, Robak T. Gora-Tybor J, et al. Among authors: robak t. Mediators Inflamm. 2003 Jun;12(3):167-71. doi: 10.1080/0962935031000134888. Mediators Inflamm. 2003. PMID: 12857600 Free PMC article.

5

Coexistence of chronic lymphocytic leukemia and essential thrombocythemia.

Robak T, Urbańska-Ryś H, Góra-Tybor J, Wawrzyniak E, Korycka A, Bartkowiak J, Kordek R, Polliack A. Robak T, et al. Leuk Lymphoma. 2003 Aug;44(8):1425-31. doi: 10.1080/1042819031000097348. Leuk Lymphoma. 2003. PMID: 12952240 Review.

6

Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies.

Robak T, Smolewski P, Urbanska-Rys H, Gora-Tybor J, Blonski JZ, Kasznicki M. Robak T, et al. Leuk Lymphoma. 2004 May;45(5):937-44. doi: 10.1080/1042819032000159825. Leuk Lymphoma. 2004. PMID: 15291352 Clinical Trial.

7

Richter's syndrome in the brain first manifested as an ischaemic stroke.

Robak T, Góra-Tybor J, Tybor K, Jamroziak K, Robak P, Kordek R, Rieske P, Majos A, Urbańska-Ryś H. Robak T, et al. Among authors: robak p. Leuk Lymphoma. 2004 Jun;45(6):1261-7. doi: 10.1080/10428190310001638823. Leuk Lymphoma. 2004. PMID: 15360010

8

Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia.

Gora-Tybor J, Blonski JZ, Robak T. Gora-Tybor J, et al. Among authors: robak t. Eur Cytokine Netw. 2005 Jan-Mar;16(1):41-6. Eur Cytokine Netw. 2005. PMID: 15809205 Free article.

9

The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.

Robak T, Blonski JZ, Kasznicki M, Góra-Tybor J, Dmoszyñska A, Skotñicki A. Robak T, et al. Haematologica. 2005 Jul;90(7):994-6. Haematologica. 2005. PMID: 15996945 Clinical Trial.

10

Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1).

Robak T, Błoński JZ, Kasznicki M, Góra-Tybor J, Dmoszyńska A, Wojtaszko M, Skotnicki AB, Nowak W, Hellmann A, Lewandowski K, Zdziarska B, Konopka L, Ceglarek B, Dwilewicz-Trojaczek J, Boguradzki P, Kuliczkowski K, Sułek K, Warzocha K. Robak T, et al. Med Sci Monit. 2005 Oct;11(10):PI71-9. Epub 2005 Sep 26. Med Sci Monit. 2005. PMID: 16192912 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

758 results

Search Page

Filters